We use cookies to provide the best possible website experience for you.
This includes cookies that are technically required to ensure a proper functioning of the website,
as well as cookies which are used solely for anonymous statistical purposes,
for more comfortable website settings, or for displaying personalized content.
You are free to choose the categories you would like to permit. Please note that depending on your settings,
the full functionality of the website may no longer be available.
Further information can be found in our Privacy Statement and Cookie Statement.
This category of cookies is required to ensure a proper functioning of our website.
Statistics
This category of cookies is needed to evaluate how you interact with our website and find out how we can improve it.
All information collected by these cookies is aggregated and therefore anonymous.
Preferences and Marketing
This category of cookies stores information about preferences you have previously selected. They are also used to track visitors across websites with the intention to display third-party content that is relevant and engaging for the individual user.
Effective polyclonal T cell activation and expansion
Polyclonal activation and expansion of T cells serves to generate large numbers of effector cells and may be required to improve gene modification, for example, during cell manufacturing processes. Miltenyi Biotec’s nano-sized polymeric matrix T Cell TransAct™, soluble antibodies, and antibody-coated cell-sized particles (ExpAct™ Treg Kit) are well suited to achieve an effective polyclonal T cell stimulation and expansion in vitro. Conjugated to humanized recombinant CD3 and CD28 agonists, the nanomatrix MACS GMP T Cell TransAct can be sterile filtered and is tailor-made for the use in automated culture performed with the CliniMACS Prodigy® Instrument.